Where is Voyager headquartered?

Voyager is located in Cambridge, MA.

Who invested in Voyager?

Voyager has 13 investors including Geekdom Fund And Geekdom Fund.

When was the last funding round for Voyager?

Voyager closed its lastf unding roundon Jul 19, 2017 from a Convertible Note round.

Company Information
Company Timeline (Coming Soon)

voyagertherapeutics.com

Voyager

Voyager is a Massachusetts-based biopharmaceutical company that develops and commercializes gene therapies for the treatment of neurological disorders.

Business Model:

Revenue: $70.5M

Employees: 51-200

Geographic Data

Address: 75 Sidney Street

City: Cambridge

State: MA

Zip: 02139

Country: US

Financial Info

Stage:

series b

Raised Last:

$60M

Raised Total:

$135M

Social

Twitter

Crunchbase

Metrics

4,101,712Website Global Rank

2,842Website Monthly Traffic

Twitter Followers

Description

Voyager is a Massachusetts-based biopharmaceutical company that develops and commercializes gene therapies for the treatment of neurological disorders.

Contact Phone:
+18572595340

Contact Email:

IPO Details

Voyager went public on 11/11/2015 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
11/11/2015

IPO Valuation:
$360M

Ticker Symbol:
VYGR

IPO Price:
$14/share

Amount Raised:
$70M

Live

Opened: -/share

EBITDA	-
Total Cash	-
Total Debt	-
Total Revenue	-
Total Profit (Gross)	-
PE Ratio	-

Investments

Announced Date	Company	Transaction	Money Raised

Funding Rounds

Announced Date	Transaction	Number of Investors	Money Raised	Lead Investors
2/2015	Corporate Round		$0	Genzyme Genzyme Genzyme Genzyme
4/2015	Series B		$0	Fidelity Management and Research Company Casdin Capital Partner Fund Management Wellington Management Brookside Capital Deerfield Brookside Capital Fidelity Management and Research Company Partner Fund Management Fidelity Management and Research Company Casdin Capital Partner Fund Management Wellington Management Brookside Capital Deerfield Brookside Capital Fidelity Management and Research Company Partner Fund Management
1/2023	Post-IPO Equity	1	$39M	Neurocrine Biosciences Neurocrine Biosciences
11/2015	IPO		$70M
11/2017	Post-IPO Equity		$62.1M
2/2014	Series A	1	$45M	Third Rock Ventures Third Rock Ventures Third Rock Ventures Third Rock Ventures
4/2015	Series B	6	$60M	Partner Fund Management Wellington Management Casdin Capital, LLC Brookside Capital Fidelity Management and Research Company Casdin Capital Partner Fund Management Wellington Management Brookside Capital Deerfield Brookside Capital Fidelity Management and Research Company Partner Fund Management
2/2015	Series B	1	$30M	Sanofi-Genzyme BioVentures Genzyme Genzyme

Acquisitions

Announced Date	Name	Price

Employee Demographics

Employee Departments

Employee States

Similar Companies

Uniview Singapore VEID	Revenue: 0 - 100000 Employees: Industry: Software	Details
Konkuk University Medical Center	Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education	Details
Daemon Technologies	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain	Details
Ace International Trade	Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial	Details
An Hòa Communications	Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising	Details